Dimitrios Chondros - SVP, Halozyme Therapeutics, Inc

As of August 5, 2019


Dimitrios Chondros Net Worth

  • Net worth is estimated to be at least $1.1M
  • Owns at least 38,584 units of Halozyme Therapeutics, Inc stock
  • Sold an estimated value of $169.45K in the last year at Halozyme Therapeutics, Inc

Dimitrios Chondros Trading

  • Largest sale of shares was 1,328 units , worth over $22.18K on August 5, 2019
  • In total has made about 8 transactions over a year
  • Usually trades in February, with the busiest year in 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Dimitrios Chondros Mailing Address

  • Mailing address is 11388 Sorrento Valley Road San Diego CA 92121 CA

Halozyme Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Helen I. Torley 2020 $791,440 - $2,500,018 $2,500,001 $712,270 $15,147 $6,518,876
Helen I. Torley 2019 $761,000 - $2,184,130 $2,184,128 $712,296 $15,572 $5,857,126
Helen I. Torley 2018 $725,000 - $2,115,640 $2,115,631 $831,665 $11,733 $5,799,669
Elaine D. Sun 2020 $395,833 $150,000 $1,500,269 $1,000,008 $180,352 $133,399 $3,359,861
Laurie D. Stelzer 2020 $93,225 - $ $ $ $77,996 $171,221
Laurie D. Stelzer 2019 $495,000 $2,500 $750,016 $750,005 $231,660 $16,939 $2,246,120
Laurie D. Stelzer 2018 $470,000 - $575,018 $575,009 $323,489 $9,409 $1,952,925
Masaru Matsuda 2020 $440,000 $50,000 $500,019 $500,008 $203,940 $13,901 $1,707,868
Michael J. LaBarre 2020 $475,000 - $650,009 $650,007 $220,163 $15,018 $2,010,197
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1159036/000115903621000019/halodefproxy2021.htm

Halozyme Therapeutics, Inc Insider Trading

  • The most recent transaction was 50,000 units sold on November 8, 2021 by Helen Torley worth over $1.99M
  • In the last 14 years, insiders at Halozyme Therapeutics, Inc sold an estimated value of $131.51M and bought an estimated value of $81.29M
  • The most active traders are Helen Torley, President and CEO,  Gregory Ian Frost, CEO,  and Randal J Kirk
  • Insider trading is most common in February and May, with the busiest year in 2007

HALOZYME THERAPEUTICS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1